NotebookLM was used to create Figure 1
Phase II of COVID-19 is considered a wide-spectrum hyperinflammatory disease, amplified by CRS from HMRD 27
Safety concerns, patent and affordability issues collide The FDA has warned about potentially substandard quality, unlabeled salt forms, and dosing errors in compounded versions
Research shows that B7 33 binds to receptors involved in tissue repair and may reduce fibrosis and scarring in some experimental models
Our work spans internationally and we collaborate with patients, drug manufacturers, patent offices, community leaders, public health professionals, policymakers, scientists, economists, and more across the globe
GLP-1 also slows down the stomach emptying, which could lead to less glucose from the food into the bloodstream